The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.
As a new anticancer treatment option, vaccinia virus (VACV) has shown remarkable antitumor activities (oncolysis) in preclinical studies, but potential infection of other organs remains a safety concern. We present here genome comparisons between the de novo sequence of GLV-1h68, a recombinant VACV, and other VACVs. The identified differences in open reading frames (ORFs) include genes encoding host-range selection, virulence and immune modulation proteins, e.g., ankyrin-like proteins, serine proteinase inhibitor SPI-2/CrmA, tumor necrosis factor (TNF) receptor homolog CrmC, semaphorin-like and interleukin-1 receptor homolog proteins. Phylogenetic analyses indicate that GLV-1h68 is closest to Lister strains but has lost several ORFs present in its parental LIVP strain, including genes encoding CrmE and a viral Golgi anti-apoptotic protein, v-GAAP. The reduced pathogenicity of GLV-1h68 is confirmed in male mice bearing C6 rat glioma and in immunocompetent mice bearing B16-F10 murine melanoma. The contribution of foreign gene expression cassettes in the F14.5L, J2R and A56R loci is analyzed, in particular the contribution of F14.5L inactivation to the reduced virulence is demonstrated by comparing the virulence of GLV-1h68 with its F14.5L-null and revertant viruses. GLV-1h68 is a promising engineered VACV variant for anticancer therapy with tumor-specific replication, reduced pathogenicity and benign tissue tropism.
Zhang
Qian
Q
Genelux Corporation, San Diego Science Center, 3030 Bunker Hill St., Ste. 310, San Diego, CA 92109, USA.
Liang
Chunguang
C
Yu
Yong A
YA
Chen
Nanhai
N
Dandekar
Thomas
T
Szalay
Aladar A
AA
D000818:Animals; D002478:Cells, Cultured; D002522:Chlorocebus aethiops; D002874:Chromosome Mapping; D005260:Female; D005814:Genes, Viral / Q000502:physiology; D016679:Genome, Viral; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008819:Mice, Nude; D008969:Molecular Sequence Data; D050504:Oncolytic Viruses / Q000235:genetics*; D016366:Open Reading Frames / Q000235:genetics; D010802:Phylogeny; D051381:Rats; D017422:Sequence Analysis, DNA; D014613:Vaccines, Attenuated / Q000235:genetics; D014616:Vaccinia virus / Q000235:genetics*; D037521:Virulence Factors / Q000235:genetics* / Q000502:physiology
D014613:Vaccines, Attenuated; D037521:Virulence Factors
Bioinformatics. 2007 Mar 15;23(6):673-9
17237039
Brief Bioinform. 2002 Sep;3(3):265-74
12230035
Methods Enzymol. 1993;217:270-9
8474334
Genome Res. 2002 Oct;12(10):1611-8
12368254
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W451-4
15980510
J Gen Virol. 2001 Sep;82(Pt 9):2083-2093
11514717
Nature. 1990 Mar 1;344(6261):36-42
2137557
Virology. 2002 Jan 20;292(2):285-98
11878931
Virology. 1962 Sep;18:9-18
14036977
FEBS Lett. 1993 Mar 15;319(1-2):163-5
8384122
Nat Biotechnol. 2004 Mar;22(3):313-20
14990953
Cancer Res. 2005 Nov 1;65(21):9991-8
16267024
J Virol. 1988 Dec;62(12):4474-80
3184271
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
7984417
J Virol. 2001 Jan;75(1):11-8
11119568
Cancer Res. 2001 Dec 15;61(24):8751-7
11751395
J Gen Virol. 1990 Sep;71 ( Pt 9):2185-90
2170578
J Virol. 1988 Mar;62(3):866-74
3339716
Virology. 1995 Jan 10;206(1):136-47
7831769
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D138-41
14681378
PLoS Pathog. 2007 Feb;3(2):e17
17319741
Mol Ther. 2005 Feb;11(2):180-95
15668130
J Virol. 2003 Jul;77(13):7590-600
12805459
Virol J. 2006 Oct 25;3:88
17062162
Proc Natl Acad Sci U S A. 1986 Aug;83(15):5573-7
3461450
Curr Gene Ther. 2005 Aug;5(4):429-43
16101516
J Virol. 2008 Oct;82(20):10079-87
18684811
Virology. 1990 Nov;179(1):247-66, 517-63
2219722
Mol Biol Evol. 2006 Feb;23(2):254-67
16221896
Nature. 1985 Oct 31-Nov 6;317(6040):813-5
4058585
Proc Natl Acad Sci U S A. 1982 Dec;79(23):7415-9
6296831
Gene. 1995 Dec 29;167(1-2):GC1-10
8566757
J Gen Virol. 1999 Apr;80 ( Pt 4):949-959
10211965
Virology. 1993 Nov;197(1):328-38
8212568
Virology. 1998 May 10;244(2):365-96
9601507
J Mol Biol. 1981 Mar 25;147(1):195-7
7265238
Immunity. 1998 Apr;8(4):473-82
9586637
Cancer Res. 2007 Oct 15;67(20):10038-46
17942938
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4640-5
16537421
J Virol. 2005 Aug;79(16):10750-63
16051867
Dokl Akad Nauk SSSR. 1985;285(3):696-9
4092585
Virology. 1990 Nov;179(1):276-86
2171207
Protein Sci. 2004 Jun;13(6):1435-48
15152081
Biochimie. 1996;78(5):364-9
8905155
BMC Bioinformatics. 2006 Oct 20;7:461
17054788
J Virol. 1990 Jun;64(6):3108-11
2159565
Nucleic Acids Res. 2005 Jan 20;33(2):511-8
15661851